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Brief Communications
FXR1P But Not FMRP Regulates the Levels of Mammalian
Brain-Specific microRNA-9 and microRNA-124
Xia-Lian Xu,1 Ruiting Zong,2 Zhaodong Li,3MdHelal Uddin Biswas,3 Zhe Fang,2David L. Nelson,2 and Fen-Biao Gao3
1Gladstone Institute of Neurological Disease, San Francisco, California 94158, 2Department of Molecular and Human Genetics, Baylor College of Medicine,
Houston, Texas 77030, and 3Department of Neurology, University of Massachusetts Medical School, Worcester, Massachusetts 01605
Mammalian brain-specificmiR-9 andmiR-124 have been implicated in several aspects of neuronal development and function. However,
it is not known how their expression levels are regulated in vivo. We found that the levels of miR-9 andmiR-124 are regulated by FXR1P
but not by the loss of FXR2P or FMRP in vivo, a mouse model of fragile X syndrome. Surprisingly, the levels of miR-9 and miR-124 are
elevated in fmr1/fxr2double-knock-outmice, inpart reflectingposttranscriptional upregulationof FXR1P. Indeed, FXR1P is required for
efficient processing of pre-miR-9 and pre-miR-124 in vitro and forms a complex with Dicer and pre-miRNAs. These findings reveal
differential roles of FMRP family proteins in controlling the expression levels of brain-specific miRNAs.
Introduction
MicroRNAs (miRNAs) are critical for posttranscriptional regu-
lation of many aspects of neuronal development and function
(Coolen and Bally-Cuif, 2009; Schratt, 2009). Among them, the
cellular context-dependent functions of miR-9 and miR-124
have been extensively studied (Gao, 2010). Both miRNAs are
specifically expressed in mammalian brains including postmi-
totic neurons (Deo et al., 2006), and their respective nucleotide
sequences are evolutionarily conserved. The levels of these neu-
ronal miRNAs are tightly regulated both spatially and tempo-
rally; however, the underlying mechanisms remain to be fully
understood.
Mature miR-9 and miR-124 are each produced from three
precursor miRNAs (pre-miRNAs) located on separate chromo-
somes, and each pre-miRNA is transcribed at different levels. For
instance, pre-miR-9-2 is predominant in the mouse embryonic
brain (Shibata et al., 2008) and human neural progenitor cells
(Delaloy et al., 2010). miRNAs levels are also affected by the
efficiency of processing by the Dicer and associated proteins, and
fromtheprimarymiRNAtranscripts (pri-miRNAs) topre-miRNAs
by the Microprocessor complex (Newman and Hammond, 2010).
Although some previously characterized RNA-binding proteins
have been implicated in these processes, such as hRNP proteins
(Gregory et al., 2004; Michlewski et al., 2008), the precise roles of
other RNA-binding proteins in regulating miRNA abundance are
unclear. Moreover, miRNAs in neurons are much less stable than
that in non-neuronal cells and can be regulated by neuronal activity
(Krol et al., 2010).
Drosophila fragile X mental retardation protein 1 (dFMR1) is
associated with the miRNAs pathway (Caudy et al., 2002; Ishi-
zuka et al., 2002). In dfmr1mutant flies, the steady-state level of
miR-124 is reduced, and the effect of miR-124 overexpression on
dendritic branching is attenuated (Xu et al., 2008). In mammals,
FMRP is homologous to two closely related proteins, FXR1P and
FXR2P (Zhang et al., 1995). All three proteins are coexpressed in
virtually all differentiated neurons (Tamanini et al., 1997). Loss
of FMRP in humans causes fragile X syndrome—the most com-
mon form of inherited intellectual disability. The molecular
functions of this protein in neuronal development and synaptic
function are incompletely understood (Waung and Huber,
2009). Among its roles, FMRP is required for miR-125b regula-
tion of NR2A expression and spine morphology (Edbauer et al.,
2010). However, it is not known whether FMRP family proteins
affect the expression levels of brain-specific miRNAs. To address
this issue, in this study, we used single or double knock-out mice
to examine the specific roles of FMRP, FXR1P, and FXR2P in
regulating miR-9 and miR-124 levels in the mammalian brain.
Materials andMethods
Mouse strains and tissue collection.Control wild-type (WT) and homozy-
gous fmr1KOmice of either sex were fromThe Jackson Laboratory.WT,
fxr2, fmr1/fxr2 double KO, and fxr1 KO mice of either sex and frozen
whole brain andmuscle tissues from themicewere from the laboratory of
D. L.Nelson.Unless indicated otherwise, experiments were conducted in
adult mice of either sex at2months of age.Mice were anesthetized and
killed by cervical dislocation, and specified tissues were immediately re-
moved for RNA isolation or protein extraction.
RNA isolation and quantitative real-time PCR (qRT-PCR) analysis.To-
tal RNAs were isolated from mouse tissues or cultured cells with Trizol
(Invitrogen) and purified with RNeasy Mini or miRNeasy kits (Qiagen).
MaturemiRNAswere detectedwith a TaqManmiRNA reverse transcrip-
tion kit followed by real-time PCR (Applied Biosystems); expression
levels were normalized toU6RNA levels.mRNA levels weremeasured by
qRT-PCR as described previously (Xu et al., 2008) and normalized to
GAPDH expression. The primers formeasuringmiR-124were as follows.
miR-124-1-forward: CGGGTAGCAGGCTTCTGAGT; miR-124-1-re-
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verse: AAACCCCTC TCTGTCGGTAGCT;
miR-124-2-forward: CCATTGGTGCAAACG-
GTCTA; miR-124-2-reverse: GTTCGACCCA-
GAATTTTATTTGGA; miR-124-3-forward:
TTTTTTCCTGTCCTC GGCAG; miR-124-
3-reverse: GCCAGAGCAGAGTCTCAT-
ACCA. The primers for measuring fxr1
transcripts were as follows: fxr1-forward1:
GGCAGAAGATAGACAGC CAGT; fxr1-
reverse1: TTCTCCCAGAGTACGCGGTAG;
fxr1-forward2: CGTCTCTTCTG TACA-
AGGTTCT AGG; fxr1-reverse2: TTCGGA-
GGGGTTAGACAGC.
Northern blot analysis.Northern blot anal-
ysis was performed as described previously
(Xu et al., 2008) with some modifications.
After the RNA transfer to the membrane,
miRNAs were detected with 5-digoxigenin-
labeled mercury-LNA probes (Exiqon) spe-
cific for individual miRNAs according to the
manufacturer’s protocol. The membrane was
then incubated with anti-digoxigenin-AP (1:
100,000 in blocking buffer) and washedmultiple
times. miRNAs were detected with CDP-Star
substrate according to themanufacturer’s proto-
col (Roche).
Generation of expression constructs. Flag-tagged
FXR1P was cloned into the 3xFlag-pCMV7.1
vector.Togeneratemouse fxr1-specific siRNAs,
six pairs of oligos were synthesized, an-
nealed, and cloned downstream of the H1
promoter into the pSuper-GFP vector (Oli-
goEngine). The effectiveness of the siRNA
constructs in HEK293T cells was determ-
ined by Western blot analysis and one was
selected for further use (sense: 5-GGCA-
AAGTGATCGGAAAGA-3; antisense: 5-
TCTTTCCGATCACTTTGCC-3).
Cell culture and Western blot analysis.
HEK293T cells were maintained in DMEM containing 10% fetal bo-
vine serum, and penicillin/streptomycin. Lipofectamine 2000 (Invit-
rogen) was used to transfect cells with expression constructs. The
following primary antibodies were used: monoclonal anti-Flag M2
antibody (Sigma), anti-FMRP (Developmental Studies Hybridoma
Bank, 7G1-1), anti-FMRP antibody (4317, Cell Signaling Technol-
ogy), goat anti-FXR1P polyclonal antibody (Abcam, ab51970), mouse
anti-FXR1P (Millipore, 6BG10); mouse anti-FXR1P antibody (4173,
Cell Signaling Technology), mouse anti-FXR2Pmonoclonal antibody
(ab37166, Abcam), and mouse anti--tubulin (Developmental Stud-
ies Hybridoma Bank).
Immunoprecipitation assay. HEK293 cells were transfected pSuper-
GFP-pre-miR-9-2 or pSuper-GFP-pre-miR-124-2 plasmids, with or
without Flag-FXR1P. After 36 h, cells were lysed using RNase-free
lysis buffer (20 mM HEPES, pH 7.4, 150 mM NaCl, 2 mM MgCl2, 0.5%
Nonidet P-40, 1 mM dithiothreitol, and protease inhibitors). The ly-
sates were incubated with anti-Flag antibody and protein-G-agarose
beads at 4°C overnight. The associated RNA was isolated by regular
Trizol (Invitrogen) protocol. Precipitated pre-miR-124-2 or pre-
miR-9-2 were detected using qRT-PCR. To detect the interaction
between FXR1P and Dicer, HEK293 cells were transfected with Flag-
FXR1P or empty vectors. Total cell lysate was prepared in 1% Triton
lysis buffer after 24 h transfection. Two percent of the cell lysate was
taken as input. The remaining cell lysate was incubated with mouse
IgG or Flag antibody and subsequently with 50 l of protein G Sep-
harose beads. After overnight incubation at 4°C, the beads were
washed and resuspended in 75 l of sample buffer. Then, 25 l sam-
ples were subjected to SDS gel electrophoresis. Western blot analysis
was performed using ant-Dicer and anti-FXR1P as primary antibodies.
Results
FXR1 but not FMRP is required to maintain the levels of
brain-specific miR-9 andmiR-124 in vivo
To determine which of the three mammalian FMRP family pro-
teins regulates the levels of brain-specific miRNAs in vivo, espe-
cially miR-9 andmiR-124, we dissected whole-brain tissues from
fxr1 or fxr2 knock-outmice (Nelson laboratory) and fmr1 knock-
out mice (Jackson Laboratory). fxr1 knock-out mice die shortly
after the birth (Mientjes et al., 2004); thus, we obtained brain
tissues from E18 embryos of fxr1 mutants and wild-type litter-
mate controls. We found by Northern blot analysis that the ex-
pression of miR-124 (Fig. 1A) and miR-9 (Fig. 1B) was
significantly lower in fxr1 knock-out embryos (Fig. 1C), suggest-
ing that FXR1P is required in vivo to regulate the levels of neuro-
nal miRNAs in the brain. The level of miR-1, a muscle-specific
miRNA critical for cardiovascular development (Liu and Olson,
2010), was also decreased by 45% in skeletal muscles of fxr1
knock-out embryos (data not shown), indicating that the role of
FXR1P is not limited to neuronal miRNAs. Misregulation of
miR-1 could contribute in part to the reported muscle defects
caused by FXR1P deficiency (Mientjes et al., 2004; Van’t Padje et
al., 2009).
FXR1P is one of the three family proteins that also include
FMRP and FXR2P. To examine the effect of loss of FMRP on
miRNA levels in the brain, we first confirmed the absence of
FMRP in the adult brains of multiple fmr1 knock-out mice by
Western blot analysis (Fig. 1D). To examinemiR-9 andmiR-124
Figure 1. The levels of brain-specific miR-9 and miR-124 are regulated by FXR1P but not FMRP or FXR2P in vivo. A, Brain
levels of miR-124 are lower in E18 fxr1 mutant embryos than in WT embryos, as shown by Northern blot. B, miR-9
expression was also decreased in embryonic mouse brains in the absence of FXR1P. C, Relative levels of miR-124 and miR-9
normalized to U6 RNA in the brains of E18 embryos. Values are mean SEM of three embryos for each genotype. The
experiment was repeated with similar results. ***p 0.001 by Student’s t test. D, Western blot analysis confirms the
absence of Fmr1 in the fmr1 KO mice in E and F. E, Northern blot analysis showing the expression level of mature miR-124
in the brains of four WT and four fmr1 KO mice at 2 months of age. U6 RNA served as the loading control. F, MiR-9 levels in
the brains of three WT and three fmr1 KOmice. G, Western blot analysis confirmed the absence of FXR2P in the fxr2 KOmice
in H. H, Expression levels of miR-124 in the brains of four WT and four fxr2 KO mice at 2 months of age. I, Expression levels
of miR-124 and miR-9 normalized to U6 RNA. Values are mean SEM of three independent experiments.
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levels, we isolated total RNAs from whole brain tissues and per-
formed Northern blot analysis. The level of miR-124 in the brain
was not affected by loss of FMRP (Fig. 1E). This experiment was
repeated three times with similar results (Fig. 1 I). Similarly,
miR-9 levels remained the same in fmr1 knock-out mice and
wild-type littermates (Fig. 1F, I). Thus, the total levels of these
brain-specificmiRNAswere not affected inmousemodel of frag-
ile X syndrome and are unlikely to be a contributing factor to its
pathogenesis in humans.
Next, we examined the effect of loss of FXR2P, a protein that is
closely related to and whose functions may overlap with those of
FMRP (Zhang et al., 2008). First, we performed Western blot
analysis and confirmed the absence of FXR2P in the adult brains
of fxr2 knock-out mice used in the following experiment (Fig.
1G). Then we analyzed miR-9 and miR-124 mRNA levels in the
brain by Northern blot analysis. No difference was observed be-
tween 2-month-old fxr2 knock-out mice and wild-type controls
(Fig. 1H, I). Thus, loss of FMRP or FXR2P alone in vivo does not
affect the expression levels of neuronal miRNAs in the brain.
The expression levels of both FXR1P and brain-specific
miRNAs are elevated in fmr1/fxr2 double knock-out mice
FMRP and FXR2P recognize unique and common RNA targets
(Darnell et al., 2009), and fmr1/fxr2 double knock-out mice ex-
hibit more severe behavioral phenotypes (Zhang et al., 2008). To
examine the effects of simultaneous loss of FMRP and FXR2P on
brain-specific miRNAs, we performed Northern blot analysis of
double knock-out mice. The expression level of miR-9 and miR-
124 (Fig. 2A,B) in the brain was significantly higher in 2-month-
old fmr1/fxr2 double-knock-out mice; Western blot analysis
confirmed the absence of FMRP and FXR2P (Fig. 2C). These
findings suggest that FMRP andFXR2Pplay redundant functions
in regulating miRNA levels or compensatory changes in the dou-
ble knock-out mice lead to elevated levels of these brain-specific
miRNAs through an indirect mechanism. Considering the im-
portance of neuronal miRNAs in brain development and func-
tion (Gao, 2010), this increase could
contribute to the reported behavioral
phenotypes in fmr1/fxr2 double-knock-
out mice (Zhang et al., 2008).
To investigate the mechanism of the ef-
fect of loss of both FMRP and FXR2P on
miRNAs, we examined the expression of
FXR1P, a closely related Fmr1 family pro-
tein (Zhang et al., 1995). Unexpectedly,
FXR1P expression in the brains of the
double-knock-outmice was 2.4-fold higher
than that inwild-typemice (p0.001) (Fig.
2D) but did not seem to be significantly af-
fected by loss of FMRP alone (p 0.5) (Fig.
2D). Thus, FMRP and FXR2P may act in
concert to regulate FXR1P expression. This
FXR1P upregulation likely occurs at the
posttranscriptional level, since the fxr1
mRNA level in the brain was unaffected by
simultaneous loss of FMRP and FXR2P in
vivo (Fig. 2E).
FXR1Pmodulates the processing
efficiency of pre-miR-9
and pre-miR-124
FXR1P affects miRNA-mediated transla-
tional regulation (Vasudevan et al., 2007),
but its role in controlling miRNA levels is unknown. In principle,
FXR1P could affect the transport, processing, or stability of pre-
miRNAs. Todistinguish these possibilities, we established an in vitro
assay system in which pre-miR-124 or pre-miR-9 was ectopically
expressed in HEK293 cells, which do not normally express these
brain-specific miRNA. Mature miR-124 is encoded by three genes
on separate chromosomes in mammals; pre-miR-124-1 and pre-
miR-124-2 are most abundant expressed (Fig. 3A). Similarly, pre-
miR-9-2 is the predominant gene expressed in human neural
precursor cells (Delaloy et al., 2010). In HEK293 cells, transfected
pre-miR-124-2 was processed (albeit inefficiently) to generate ma-
ture miR-124 (Fig. 3C). Overexpression of Flag-tagged FXR1P in
HEK293cells (Fig. 3B) increased the level ofmaturemiR-124 inadose-
dependent manner (Fig. 3C,D). Similarly, transfected pre-miR-9-2
couldbeprocessed intomaturemiR-9 (Fig. 3E).Theapparent lowpro-
cessing efficiency is probably due to the high level of the transient over-
expression of the miRNA precursor. Concomitant overexpression of
FXR1P resulted in an increase in the level ofmaturemiR-9 and likely a
decrease in the level of the pre-miR-9-2 (Fig. 3E,F), suggesting that
FXR1Ppromotes efficient processing of both brain-specificmiRNAs.
Todemonstrateadirect role forFXR1PinmiRNAprocessing,we
expressed both FXR1P and pre-miR-124-2 (or pre-miR-9-2) in
HEK293 cells and performed coimmunoprecipitation experiments.
qRT-PCRanalysis indicates that overexpressionof FXR1Pdecreases
the level of miRNA precursors (Fig. 3G,H), consistent with the
Northern blot analysis (Fig. 3C–F). Pre-miR-124-2 or pre-miR-9-2
could be found in the immunoisolates after FXR1P pull down using
an Flag antibody (Fig. 3G,H), indicating that FXR1P and miRNA
precursors form a common complex. Moreover, FXR1P was found
to complexwithDicer, a dsRNAnuclease essential for thebiogenesis
of most miRNAs (Fig. 3I). FXR1P had no effect on the steady-state
expression level of Dicer (Fig. 3J). Together, these findings are con-
sistentwith thenotion thatFXR1Paffects theprocessingefficiencyof
Dicer on brain-specific miRNAs.
To further confirm the function of FXR1P in regulating
miRNA levels, we also performed loss of function analysis in the
Figure 2. The levels of brain-specificmiR-9 andmiR-124 are elevated in fmr1/fxr2 double-knock-out (KO)mice.A, The levels of
miR-9 andmiR-124 are significantly elevated in the brains of fmr1/fxr2double-KOmice at 2months of age.B, Quantification of the
levels of miR-9 and miR-124 in the brains of 2-month-old WT, fmr1 KO, and fmr1/fxr2 double-KO mice. Values are mean SEM
(n2–4miceper genotype).p0.001byStudent’s t test for fmr1/fxr2double-KOmice comparedwithWT. Theexperimentwas
repeated with similar results. C, Western blot analysis confirmed the absence of Fmr1 in single-KO mice and FMRP and FXR2P in
double-KO mice. D, Western blot analysis revealed a 2.4-fold increase in FXR1P expression in fmr1/fxr2 double-KO mice (p
0.001). Equal amounts of protein lysateswere loaded in each lane.E, Real-timeRT-PCR showed that fxr1mRNA levels remained the
same in the brains of fmr1 and fxr2 single- or double-KO mice. Values are mean SEM of three independent experiments.
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HEK293 assay system. fxr1-specific siRNAs effectively decreased
the expression of FXR1P in HEK293 cells (Fig. 4D). Knockdown
of endogenous FXR1P decreased the level of mature miR-124
processed from the transfected precursor molecules in HEK293
cells (Fig. 4A,B). Similarly, processing of transfected pre-miR-
9-2 into mature miR-9 was also compromised in the absence of
endogenous FXR1P (Fig. 4B,C), consistent with out earlier find-
ing that miR-9 or miR-124 levels were reduced in the embryonic
brains of fxr1 knock-out mice (Fig. 1).
Discussion
In this study, biochemical analysis of several knock-out mouse
lines revealed that loss of FMRP or FXR2P alone does not affect
the expression of miR-9 and miR-124 in vivo. Surprisingly, the
levels of brain-specific miR-9 and miR-124 and FXR1P were in-
creased in fmr1/fxr2 double-knock-out mice, and FXR1P was
required tomaintain proper expression levels of miR-9 andmiR-
124 in vivo. These results reveal that the total levels of these brain-
specific miRNAs are regulated by FXR1P but are unchanged in a
mouse model of fragile X syndrome.
InDrosophila, dFMR1 is required to maintain the proper lev-
els of neuron-specific miR-124 (Xu et al., 2008), a function that
seems to be conserved with FXR1P but not FMRP in mammals,
which is consistent with comparative genomic sequence analysis
indicating a closer similarity between dFMR1 and FXR proteins
(Kirkpatrick et al., 2001). Such a functional divergence of mam-
malian homologs of fly proteins is not uncommon.
Although all three proteins are widely expressed in mammals,
individual knock-out of fmr1 or fxr2 does not lead to gross defects
in brain development or decreased survival (The Dutch-Belgian
Fragile X Consortium et al., 1994; Gu et al., 2002). In contrast,
fxr1 knock-out mice die shortly after the birth (Mientjes et al.,
2004), suggesting an essential role for FXR1P in development.
However, the precise molecular function of FXR1P is poorly un-
derstood. In human cell lines, FXR1P is involved in cell-cycle-
dependent translational regulation through AU-rich elements
and miRNAs (Vasudevan and Steitz, 2007; Vasudevan et al.,
2007). Our findings reveal a role for FXR1P in controlling the
abundance of neuronal miRNAs. This requirement for FXR1P is
not restricted to the nervous system, since muscle-specific miR-1
is also regulated by FXR1P. Thus, the reported neuronal and
muscular defects in fxr1 knock-out mice could be caused in part
by defects in the miRNA pathway. Moreover, fmr1/fxr2 double
knock-out mice exhibited a loss of rhythmic activity in a light:
dark cycle (Zhang et al., 2008), which could be at least in part
Figure 3. FXR1P affects the processing efficiency of pre-miR124 or pre-miR-9 by Dicer in
HEK293 cells. A, The relative expression levels of three miR-124 precursors in the adult mouse
brain as measured by quantitative RT-PCR. B, Western blot analysis with anti-Flag antibody
confirmed the ectopic expression of transfected FXR1P in HEK293 cells. C, Overexpression of
Flag-FXR1P in HEK293 cells increased the steady-state level of miR-124 processed from trans-
fected pre-miR-124-2.D, Relative miR-124 levels in transfected HEK293 cells with FXR1P over-
expression. E, Overexpression of Flag-FXR1P in HEK293 cells increased the steady-state level of
miR-9 processed from transfected pre-miR-9-2. F, Quantification of relative miR-124 levels in
transfected HEK293 cells with FXR1P overexpression. Values are mean SEM of three inde-
pendent experiments. **p 0.01 by Student’s t test. G, H, qRT-PCR analysis indicates that
pre-miR-124-2 (G) or pre-miR-9-2 (H ) formed a complex with FXR1P. I, Co-IP experiment
demonstrates an association between Dicer and FXR1P in HEK293 cells. IP, Immunoprecipita-
tion with Flag antibody. J, FXR1P does not affect the steady-state level of Dicer expression as
shown by Western blot analysis.
Figure 4. Loss of endogenous FXR1P affects the efficient processing of transfected brain-
specificmiRNAprecursors.A, The level ofmaturemiR-124 processed from transfected pre-miR-
124-2 was reduced in the absence of FXR1P. Two independent siRNA knockdown experiments
are presented in this panel. B, The level of mature miR-9 processed from transfected pre-miR-
9-2was reduced in the absence of FXR1P. Two independent siRNA knockdown experiments are
presented in this panel. C, Quantification of the levels of mature miR-9 and miR-124 in the
presenceof absenceof endogenous FXR1P.D, Fxr1 siRNAeffectively decreased theexpressionof
FXR1P in HEK293 cells, as shown byWestern blot analysis. Asterisk indicates a nonspecific band
recognized by the anti-FXR1P antibody. Lanes 3 and 4 are two independent knockdown exper-
iments to show the effectiveness of the fxr1 siRNA.
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contributed by the misregulated miRNA pathway as in flies
(Kadener et al., 2009).
The expression ofmiRNAs can be influenced at the both tran-
scriptional andposttranscriptional levels.Our results suggest that
FXR1P is required for efficient processing of neuronalmiRNAs in
vivo. In DT40, a conditional Dicer knockdown cell line, FXR1P
but not FMRP is increased uponDicer knockdown and FXR1P is
subject to miRNA-mediated suppression (Cheever et al., 2010).
Thus, FXR1P and certainmiRNAsmay form a feedback loop that
tightly regulates each other’s expression.
Our results suggest that the levels of brain-specific miR-9 and
miR-124 are not affected in amousemodel of fragile X syndrome,
raising the possibility that the abundance of miRNAs, at least
those examined here, does not contribute to the pathogenesis of
this disorder. It remains to be determined whether the levels of
other miRNAs in vivo are selectively affected by loss of FMRP
alone and the extent to which misregulation of the miRNA path-
way contributes to the molecular pathogenesis of fragile X
syndrome.
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